Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
advances in neurology
adverse drug reaction
algorithm
ambient cistern
ambient cistern, effacement
amyloid angiopathy, cerebral
aneurysm
aneurysm, intracranial
aneurysm, intracranial, acute deterioration
aneurysm, intracranial, treatment of
angiography, cerebral
anticoagulant, complications of
anticoagulant, restarting
anticoagulant, reversal of
anticoagulant, treatment
anticonvulsants
asymptomatic
ataxia
basal ganglia, hemorrhage
basal ganglia, infarction
basilar artery
basilar artery occlusion
blood pressure
blood pressure, control
blood pressure, lowering
brainstem, hematoma
brainstem, hemorrhage, primary
brainstem, vascular malformation of
carotid artery disease
carotid artery occlusion, intracranial
CAT scan
CAT scan, abnormal
CAT scan, angiography
CAT scan, mass effect on
CAT scan, stereotactic localization
cerebellar hemorrhage
cerebellar infarction
cerebral embolism, mechanical extraction
cerebral infarction, hemorrhagic
cerebral venous infarction
cerebral venous thrombosis
cerebrovascular accident
cerebrovascular accident, acute management of
cerebrovascular accident, clinical diagnosis
cerebrovascular accident, complications with
cerebrovascular accident, nontreatment of
cerebrovascular accident, prevention of
cerebrovascular accident, prognosis in
cerebrovascular accident, surgical treatment of
cerebrovascular accident, thrombolytic agents in treatment
cerebrovascular accident, time of onset
cerebrovascular accident, time to treatment
cerebrovascular accident, volume
cerebrovascular accident, work up for
cerebrovascular disease, surgical treatment of
clot burden
clot length
complications
controversies in neurology
coronary thrombolysis
coumarin
craniectomy, decompressive
craniotomy
critical care unit
disability, neurological
do not resuscitate
door to needle time
drug abuse
dying
efficacy
emergencies, neurologic
emergency room
emergency room, treatment of stroke
endoscopic surgery
endovascular therapy
ENRICH trial
epidemiology of neurology
evidence-based research
fibrinolytic agents
fibrinolytic agents, complications
fibrinolytic therapy, selection criteria
fibrinolytic therapy, timing of administration
gadolinium
gastrointestinal bleeding
Glasgow coma score
head injury
headache
hematoma, intracerebral
hemorrhage, putamenal
hemorrhage, thalamic
hemostatic therapy
heralding manifestation
herniation syndromes, intracranial
hydrocephalus
hydrocephalus, treatment of
hypertension
iatrogenic neurologic disorders
incidence
intracerebral hemorrhage
intracerebral hemorrhage, causes of
intracerebral hemorrhage, clot evacuation
intracerebral hemorrhage, differential diagnosis of
intracerebral hemorrhage, incidence of
intracerebral hemorrhage, lobar
intracerebral hemorrhage, location of
intracerebral hemorrhage, medical management
intracerebral hemorrhage, multiple
intracerebral hemorrhage, pathophysiology
intracerebral hemorrhage, progression of
intracerebral hemorrhage, recurrent
intracerebral hemorrhage, small
intracerebral hemorrhage, treatment of
intracerebral hemorrhage, volume
intracranial hemorrhage
intracranial pressure monitoring
intracranial pressure, increased
intracranial pressure, increased, treatment of
intraventricular hemorrhage
intraventricular hemorrhage, clot evacuation
intraventricular hemorrhage, treatment
intubation
ischemic core
level of consciousness
level of consciousness, decreased
life expectancy
life support, withdrawal of
life support, withholding of
malformation, vascular
malformation, vascular, cerebral
malformation, vascular, cryptic
microsurgery
middle cerebral artery
middle cerebral artery, occlusion of
minimally invasive surgery
mortality
MRI
MRI, abnormal
MRI, ADC maps
MRI, CAT scan compared to
MRI, contrast enhanced
MRI, diffusion weighted
MRI, early changes in CVA
MRI, gradient echo, vessel sign
MRI, susceptibility weighted
MRI, volumetry
myocardial infarction
myocardial infarction, acute
neoplasm, metastatic to CNS
neoplasm, metastatic to CNS, hemorrhagic
neoplasm, metastatic to CNS-hemorrhage into
neoplasm, primary of CNS
neoplasm, primary of CNS-hemorrhage in
neurologic complications of, surgery
neurologic disease, diagnoses of
neurologic examination
neurological intensive care
patient selection
platelet inhibiting drugs
pontine hemorrhage
practice guidelines
prevention of neurologic disorders
prognosis
race
Rankin score
recanalization, arterial
recombinant activated factor VII
reperfusion
Retriever Device
review article
risk factors
safety
seizure
seizure, prevention of
shunt procedure, ventricular
solitaire device
Spot sign
stereotaxic surgery
STITCH II trial
streptokinase
subarachnoid hemorrhage
subdural hematoma
SWIFT PRIME Trials
syncope
thrombectomy
tissue plasminogen activator, intravenous
tranexamic acid
treatment of neurologic disorder
urokinase
ventriculostomy
ventriculostomy, endoscopic
vertigo
workup
Showing articles 950 to 1000 of 1391 << Previous Next >>

rtPA Intravenous Thrombolysis in Anterior Choroidal Artery Territory Stroke
Neurol 54:666-673, Trouillas,P.,et al, 2000

Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke in Patients Aged 80 Years and Older, The tPa Stroke Survey Experience
Stroke 31:370-375, Tanne,D.,et al, 2000

Treating Acute Stroke Patients with Intravenous tPA, The OSF Stroke Network Experience
Stroke 31:77-81, Wang,D.Z.,et al, 2000

Stroke Treatment with Tissue Plasminogen Activator in the Setting of Aortic Dissection
Neurol 54:1010, Fessler,A.J. & Alberts,M.J., 2000

Neurological Emergencies: Acute Stroke
JNNP 68:277-288, Davenport,R. & Dennis,M., 2000

Intravenous Tissue-Type Plasminogen Activator for Treatment of Acute Stroke
JAMA 283:1145-1150,1189, Albers,G.W.,et al, 2000

Use of Tissue-Type Plasminogen Activator for Acute Ischemic Stroke
JAMA 283:1151-1158,1189, Katzan,I.L.,et al, 2000

Glatiramer Acetate (Copaxone) Treatment in Relapsing-Remitting MS
Neurol 54:813-817, Ge,Y.,et al, 2000

Progressive Cerebral Atrophy in MS
Neurol 54:807-812,782, Fox,N.C.,et al, 2000

Immune Cytopenias as the Presenting Finding in Primary Sjogrens Syndrome
QJM 93:825-829, Schattner,A.,et al, 2000

Detection of Patent Foramen Ovale. Transesophageal Echocardiography and Transcranial Doppler Sonography With Ultrasound Contrast Media are "Supplementary, Not Competing, Diagnostic Methods"
Med Klin 94:367-370, Heckmann,J.G.,et al, 1999

Quantitative MRI in Patients with Clinically Isolated Syndromes Suggestive of Demyelination
Neurol 52:599-606, Sailer,M.,et al, 1999

Arterial Gas Embolism after Decompression:Correlation with Right-to-Left Shunting
Neurol 52:401-404, Ries,S.,et al, 1999

CT Angiography and Doppler Sonography for Emergency Assessment in Acute Basilar Artery Ischemia
Stroke 30:606-612, Brandt,T.,et al, 1999

Diagnosis and Treatment of Ischemic Stroke
Am J Med 106:211-221, Alberts,M.J., 1999

Acute Vertebrobasilar Occlusion:Treatment with High-Dose Intraarterial Urokinase
AJR 172:709-712, Hoffman,A.I.,et al, 1999

Rapid Thrombectomy of Superior Sagittal Sinus and Transverse Sinus Thrombosis with a Rheolytic Catheter Device
AJNR 20:414-417, Opatowsky,M.J.,et al, 1999

Application of a Rheolytic Thrombectomy Device in the Treatment of Dural Sinus Thrombosis:A New Technique
AJNR 20:568-570, Dowd,C.F.,et al, 1999

Evidence of Anaphylaxy after Alteplase Infusion
Stroke 30:1142-1143, Rudolf,J.,et al, 1999

Quantitative MRI in CADASIL, Correlation with Disability and Cognitive Performance
Neurol 52:1361-1367, Dichgans,M.,et al, 1999

Superselective Intraarterial Fibrinolysis in Central Retinal Artery Occlusion
AJNR 20:565-567, Padolecchia,R.,et al, 1999

Association of Hyperdense Middle Cerebral Artery Sign with Clinical Outcome in Patients Treated with Tissue Plasminogen Activator
Stroke 30:769-772, Manelfe,C.,et al, 1999

Evaluation of Early Reperfusion and IV tPA Therapy Using Diffuion- and Perfusion-Weighted MRI
Neurol 52:1792-1798,1733, Marks,M.P.,et al, 1999

Effects of Tissue Plasminogen Activator for Acute Ischemic Stroke at One Year
NEJM 340:1781-1787, Kwiatkowski,T.G.,et al, 1999

Applications of Diffusion-Perfusion Magnetic Resonance Imaging in Acute Ischemic Stroke
Neurol 52:1750-1756,1733, Fisher,M.&Albers,G.W., 1999

Initial Clinical Experience with IV Tissue Plasminogen Activator for Acute Ischemic Stroke:A Multicenter Survey
Neurol 53:424-427, Tanne,D.,et al, 1999

Consent Issues in the Management of Cerebrovascular Diseases, A Position Paper of the American Academy of Neurology Ethics and Humanities Subcommittee
Neurol 53:9-11, , 1999

Presenting Features and Value of Diagnostic Procedures in Leptomeningeal Metastases
Neurol 53:382-385, van Oostenbrugge,R.J.&Twijnstra,A., 1999

Prethrombotic Disorders in Children with Arterial Ischemic Stroke and Sinovenous Thrombosis
Arch Neurol 56:967-971, Bonduel,M.,et al, 1999

Intraarterial Thrombolysis for Treatment of Acute Stroke:Experience in 26 Patients with Long-Term Follow-Up
AJNR 20:1291-1299, 1194, Jahan,R.,et al, 1999

Is the Routine Use of Intravenous Immunoglobulin Treatment in Neurologic Disorders Justified?
Arch Neurol 56:1028-1032, Karussis,D.&Abramsky,O., 1999

Agreement and Variability in the Interpretation of Early CT Changes in Stroke Patients Qualifying for Intravenous rtPA Therapy
Stroke 30:1528-1533, Grotta,J.C.,et al, 1999

Removal of a Thrombus from the Sigmoid and Transverse Sinuses with a Rheolytic Thrombectomy Catheter
AJNR 20:1467-1469, Scarrow,A.M.,et al, 1999

Treatment and Secondary Prevention of Stroke:Evidence, Costs, and Effects on Individuals and Populations
Lancet 354:1457-1463, Hankey,G.J.&Warlow,C.P., 1999

Intra-Arterial Cerebral Thrombolysis for Acutre Ischemic Stroke in a Community Hospital
AJNR 20:1682-1687,1580, Edwards,M.T.,et al, 1999

Predictors of Clinical Improvement,Angiographic Recanalization, and Intracranial Hemorrhage After Intra-Arterial Thrombolysis for Acute Ischemic Stroke
Stroke 30:2094-2100, Suarez,J.I.,et al, 1999

Expanding the Window for Thrombolytic Therapy in Acute Stroke, The Potential Role of Acute MRI for Patient Selection
Stroke 30:2230-2237, Albers,G.W., 1999

MRI Features of Intracerebral Hemorrhage Within 2 Hours from Symptom Onset
Stroke 30:2263-2267, Linfante,I.,et al, 1999

The Intensive Care Management of Acute Ischemic Stroke
The Neurologist 5:313-325, Deibert,E.&Diringer,M.N., 1999

Intra-Arterial Prourokinase for Acute Ischemic Stroke, The PROACT II Study:A Randomized Controlled Trial
JAMA 282:2003-2011, Furlan,A.,et al, 1999

Combined Intravenous and Intra-Arterial r-TPA Versus Intra-Arterial Therapy of Acute Ischemic Stroke, Emergency Management of Stroke (EMS) Bridging Trial
Stroke 30:2598-2605, Lewandowski,C.A.,et al, 1999

Recombinant Tissue-Type Plasminogen Activator (Alteplase) for Ischemic Stroke 3 to 5 Hours After Symptom Onset, The ATLANTIS Study:A Randomized Controlled Trial
JAMA 282:2019-2026, Clark,W.M.,et al, 1999

Cerebral Venous Thrombosis
The Neurologist 5:326-349, Biousse,V.&Bousser,M., 1999

Magnetic Resonance Imaging-Based Volumetry Differentiates Idiopathic Parkinson's Syndrome from Multiple System Atrophy and Progressive Supranuclear Palsy
Ann Neurol 45:65-74, Schulz,J.B.,et al, 1999

Cerebral Venous Thrombosis,Combined Intrathrombus rtPA and Intravenous Heparin
Stroke 30:489-494,481, Frey,J.L.,et al, 1999

Cerebral Venous Thrombosis,Nothing,Heparin,or Local Thrombolysis?
Stroke 30:481-483, Bousser,M-G, 1999

Serum Glucose Level and Diabetes Predict Tissue Plasminogen Activator-Related Intracerebral Hemorrhage in Acute Ischemic Stroke
Stroke 30:34-39, Demchuk,A.M.,et al, 1999

Evaluation of Early Computed Tomographic Findings in Acute Ischemic Stroke
Stroke 30:389-392, Marks,M.P.,et al, 1999

"Telestroke",The Application of Telemedicine for Stroke
Stroke 30:464-469, Levine,S.R.&Gorman,M., 1999

Intra-Arterial rtPA Treatment of Stroke Assessed by Diffusion- and Perfusion-Weighted MRI
Stroke 30:678-680, Lansberg,M.G.,et al, 1999



Showing articles 950 to 1000 of 1391 << Previous Next >>